Stock Market Sleeps On Stereotaxis MAGiC CE Mark
Stereotaxis gains CE Mark for MAGiC catheter, boosting revenue with high margins. FDA approval expected soon. Click here to ...
SMA15h
FDA approves new tablet version of oral SMA treatment Evrysdi
The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...
Alnylam: Waiting For Regulatory Updates In March
Alnylam awaits FDA decisions on Amvuttra & Fitusiran next month, poised to boost revenue, profitability, and share growth.
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...
The FDA just approved a new painkiller. Is it too good to be true?
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
Palm Beach Post14d
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The drug, suzetrigine ... Journavx will be priced at $15.50 per pill. The FDA-approved medication, available as a 50-milligram prescription tablet taken every 12 hours, offers a non-opioid ...
Sixers Wire14d
FDA approves new pain medicine as opioid alternative. What to know about Journavx
Vertex Pharmaceuticals announced that Journavx will be priced at $15.50 per pill. The FDA-approved medication, available as a 50-milligram prescription tablet taken every 12 hours ... In 2021, the ...